Propagenix

Cell models and cell-based therapies using its Conditional Replication (CR) technology

placeGaithersburg, Maryland, United States calendar_todayFounded 2014 groups5 employees language propagenix.com

Innovation

4 patent families (3 granted) — focus: Chemistry & metallurgy, Mechanical engineering; filing pace slowing. Cited 1,660 times.

YearFilings
20161
20172
20183
20192
20203
20213
20221
20231
20241
20252

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital133%
Accelerator & incubator133%
Other / undisclosed133%
Coming soon